Venture capital firm Catalio Capital Management announced today the closing of its more than $400 million Fund IV, as first reported by Bloomberg. The fund will continue the firm’s thesis of backing healthcare and biotechnology companies. The firm was founded in 2020 and has made more than 100 investments, according to Pitchbook. Catalio’s Fund IV, […]
This site uses User Verification plugin to reduce spam. See how your comment data is processed.